NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Admedus Ltd (ASX:AHZ), a specialist healthcare company that delivers innovative medical technologies and devices, has adopted its industry-leading cloud technology. The Australian-based listed company is leveraging the Medidata Clinical Cloud® platform to bring speed, efficiencies and enhanced decision-making to its clinical development of a therapeutic vaccine for genital herpes (HSV-2), aimed at activating a T-cell response against the virus to benefit sufferers.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
